Y-mAbs Therapeutics, Inc. (YMAB) CEO Claus Moller on Q2 2021 Results – Earnings Call Transcript

Y-mAbs Therapeutics, Inc. (YMAB) Q2 2021 Earnings Conference Call August 6, 2021 9:00 AM ET
Company Participants
Thomas Gad – Founder, Chairman & President
Claus Moller – Chief Executive Officer
Bo Kruse – Chief Financial Officer
Conference Call Participants

Click here to view the original article.